Precision for all children: embedding equity into precision medicine for children - Scorecard - MDSpire

Precision for all children: embedding equity into precision medicine for children

  • By

  • Victor Do

  • Justin Lam

  • Sanjay Mahant

  • Eyal Cohen

  • Indra Narang

  • Astrid Guttmann

  • Damien Noone

  • July 2, 2026

  • 0 min

Share

Clinical Scorecard: Ensuring Equity in Precision Medicine: A Focus on Pediatric Care for All Children

At a Glance

CategoryDetail
ConditionPrecision Medicine in Pediatrics
Key MechanismsGenomic technologies, biomarker-guided therapies, predictive analytics, individualized prevention and treatment strategies.
Target PopulationChildren, particularly from structurally marginalized communities.
Care SettingPediatric healthcare institutions and initiatives.

Key Highlights

  • Precision medicine aims to improve health outcomes by considering genetic, environmental, and lifestyle factors.
  • Barriers to access persist for many children, particularly those from marginalized backgrounds.
  • The PCH Equity framework emphasizes equitable access and representation in precision health innovations.
  • Structural inequities shape access to genetic testing and therapies.
  • Equity must be embedded in precision medicine to avoid amplifying existing disparities.

Guideline-Based Recommendations

Diagnosis

  • Integrate demographic and contextual factors in precision medicine initiatives.

Management

  • Ensure equitable access to genomic testing, advanced diagnostics, and targeted therapies.

Monitoring & Follow-up

  • Assess who benefits from precision health innovations and who may be left behind.

Risks

  • Potential for precision medicine to reproduce existing health disparities.

Patient & Prescribing Data

Children, especially those from structurally marginalized communities.

Access to precision health innovations must consider socioeconomic supports and cultural humility.

Clinical Best Practices

  • Focus on equitable access to precision health innovations.
  • Address barriers influencing access to genomic testing and advanced diagnostics.
  • Complement precision medicine with investments in public health and universal access to care.

Related Resources & Content

    Original Source(s)

    Related Content